BIOMAT Database Logo BIOMAT Database Logo

Aminoglycoside nephrotoxicity and creatinine clearance. 1984

A H Moss, and F C Whittier

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

A H Moss, and F C Whittier
Liver disease, creatinine clearance, and aminoglycoside nephrotoxicity.
August 1984, Annals of internal medicine,
A H Moss, and F C Whittier
Estimating aminoglycoside clearance and creatinine clearance in underweight patients.
February 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
A H Moss, and F C Whittier
Comparison of aminoglycoside clearance and calculated serum creatinine clearances.
January 1989, Therapeutic drug monitoring,
A H Moss, and F C Whittier
Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients.
August 1991, Critical care medicine,
A H Moss, and F C Whittier
Aminoglycoside and nephrotoxicity.
January 1988, Renal physiology,
A H Moss, and F C Whittier
Aminoglycoside nephrotoxicity.
January 1997, Seminars in nephrology,
A H Moss, and F C Whittier
Aminoglycoside nephrotoxicity.
March 1990, The American journal of medicine,
A H Moss, and F C Whittier
Aminoglycoside nephrotoxicity.
November 1980, Kidney international,
A H Moss, and F C Whittier
Aminoglycoside nephrotoxicity.
January 1986, Toxicologic pathology,
A H Moss, and F C Whittier
Aminoglycoside nephrotoxicity.
January 1977, The Western journal of medicine,
Copied contents to your clipboard!